Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,437-2,448 of 4,306
Drug study icon
CompletedNCT00615433

Lurasidone HCl A Phase 3 Study of people with Acute Schizophrenia

This study is completed in the United States, in Colombia, in India, .... It focuses on schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 75 Years
Countries
United States, Colombia, India, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT01821378

Lurasidone Low-Dose - High-Dose Study Study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 75 Years
Countries
United States, Colombia, Romania, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia
Other study type icon
CompletedNCT00350805

Measuring Time Windows in people with Schizophrenia and Healthy Controls

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Créteil
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 50 Years
Countries
France
Sponsor
University Hospital, Strasbourg, France
Condition
Schizophrenia
Drug study icon
CompletedNCT01391390

Melatonin Treatment for Tardive Dyskinesia in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Beijing
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 70 Years
Countries
China
Sponsor
Beijing HuiLongGuan Hospital
Condition
Schizophrenia
Drug study icon
CompletedNCT00757978

Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms

This summary needs review. Please check the official study record and contact the research team for details.

In Porto Alegre
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
Brazil
Sponsor
Hospital de Clinicas de Porto Alegre
Condition
Schizophrenia
Drug study icon
CompletedNCT00466310

Metabolic Signatures and Biomarkers in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Butner
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Duke University
Condition
Schizophrenia
Other study type icon
CompletedNCT00957294

Metabolic Syndrome in people with First-episode Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Aarhus
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalFrom 18 Years to 50 Years
Countries
Denmark
Sponsor
Aarhus University Hospital
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.